Cellular Uptake and Fate of PEGylated Gold Nanoparticles is Dependent on Both Cell-penetration Peptides and Particle Size
Overview
Authors
Affiliations
Numerous studies have examined how the cellular delivery of gold nanoparticles (AuNPs) is influenced by different physical and chemical characteristics; however, the complex relationship between AuNP size, uptake efficiency and intracellular localization remains only partially understood. Here we examine the cellular uptake of a series of AuNPs ranging in diameter from 2.4 to 89 nm that are synthesized and made soluble with poly(ethylene glycol)-functionalized dithiolane ligands terminating in either carboxyl or methoxy groups and covalently conjugated to cell penetrating peptides. Following synthesis, extensive physical characterization of the AuNPs was performed with UV-vis absorption, gel electrophoresis, zeta potential, dynamic light scattering, and high resolution transmission electron microscopy. Uptake efficiency and intracellular localization of the AuNP-peptide conjugates in a model COS-1 cell line were probed with a combination of silver staining, fluorescent counterstaining, and dual mode fluorescence coupled to nonfluorescent scattering. Our findings show that AuNP cellular uptake is directly dependent on the surface display of the cell-penetrating peptide and that the ultimate intracellular destination is further determined by AuNP diameter. The smallest 2.4 nm AuNPs were found to localize in the nucleus, while intermediate 5.5 and 8.2 nm particles were partially delivered into the cytoplasm, showing a primarily perinuclear fate along with a portion of the nanoparticles appearing to remain at the membrane. The 16 nm and larger AuNPs did not enter the cells and were located at the cellular periphery. A preliminary assessment of cytotoxicity demonstrated minimal effects on cellular viability following peptide-mediated uptake.
Sikora J, Blaszkiewicz P, Dudkowiak A, Jagielska J, Zurawski J Contemp Oncol (Pozn). 2025; 28(4):326-334.
PMID: 39935760 PMC: 11809566. DOI: 10.5114/wo.2024.146995.
Nanoparticle-Based Drug Delivery for Vascular Applications.
Naskar A, Kilari S, Baranwal G, Kane J, Misra S Bioengineering (Basel). 2025; 11(12.
PMID: 39768040 PMC: 11673055. DOI: 10.3390/bioengineering11121222.
Gold nanoparticles as innovative therapeutics for oral mucositis: A review of current evidence.
Choudhury M, Brunton P, Dias G, Schwass D, Meledandri C, Ratnayake J Drug Deliv Transl Res. 2024; .
PMID: 39625578 DOI: 10.1007/s13346-024-01748-x.
Assessment of CRISPRa-mediated overexpression in an Parkinson's disease model.
Guzman-Sastoque P, Sotelo S, Esmeral N, Albarracin S, Sutachan J, Reyes L Front Bioeng Biotechnol. 2024; 12:1420183.
PMID: 39175618 PMC: 11338903. DOI: 10.3389/fbioe.2024.1420183.
Visualizing the 4D Impact of Gold Nanoparticles on DNA.
Abdelhady H, Aleanizy F, Alqahtani F, Bukhari A, Soliman S, Sau S Int J Mol Sci. 2024; 25(1).
PMID: 38203711 PMC: 10778996. DOI: 10.3390/ijms25010542.